President Biden announced the appointment of Dr. Mandy Cohen as director of the CDC
On Jun. 16, 2023, President Biden announced the appointment of Dr. Mandy Cohen as Director of the Centers…
On Jun. 16, 2023, President Biden announced the appointment of Dr. Mandy Cohen as Director of the Centers…
On Jul. 6, 2022, LabCorp announced that it had begun testing for mpox using the U.S. Centers for…
On May 18, 2022, LabCorp announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and…
On Mar. 30, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service confirmed the…
On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
On Sept. 2, 2021, Thermo Fisher Scientific announced a $192.5 million contract award from the U.S. Department of…
On Sept. 1, 2021, Quidel announced it will make Quidel’s non-prescription QuickVue® At-Home OTC COVID-19 Test available to…
On Aug. 30, 2021, OPKO announced completion of enrollment in its Phase 2 trial with RAYALDEEᆴ as a…
On Jun. 11, 2021, Quidel announced today that it had received an amended Emergency Use Authorization (EUA) from…
On Jun. 8, 2021, LabCorp announced that its Pixel COVID-19 PCR Test Home Collection Kits were availavle in…
On Jun. 4, 2021, The U.S. Food and Drug Administration (FDA) approved Chimerix’s Tembexa (brincidofovir) tablets and oral…
On May 24, 2021, LabCorp reported that nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2…
On Mar. 31, 2021, Quidel announced that it had received an Emergency Use Authorization (EUA) from the U.S….
On Mar. 25, 2021, an international team of scientists announced they had found evidence that SARS-CoV-2 infects cells…
On Mar. 10, 2021, the U.S. Department of Defense (DOD) announced that it had identified additional personnel authorized…
On Dec. 7, 2020, Chimerix announced the U.S. Food and Drug Administration (FDA) had accepted the filing of a…
On Sept. 16, 2020, the National Institutes of Health (NIH) announced a $12 million award for outreach and…
On Sept. 15, 2020, Thermo Fisher Scientific announced it was investing more than $140 million to further expand…
On Sept. 15, 2020, OPKO Health announce it had initiated a Phase 2 trial with RAYALDEEᆴ as a…
On Sept. 8, 2020, LabCorp announced the launch of the first testing method to simultaneously detect COVID-19, influenza…
On Sept. 8, 2020, INOVIO announced that Thermo Fisher Scientific, the world leader in serving science, had signed…
On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
On Aug. 27, 2020, RedHill Biopharma announced that its U.S. Phase 2 study with opaganib (Yeliva®, ABC294640) in…
On Aug. 24, 2020, the Quest Diagnostics Foundation announced a wide-ranging initiative to address and reduce health disparities…
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofia SARS…
On Aug. 12, 2020, Thermo Fisher Scientific announced it had committed to supporting the efforts of historically black…
On Aug. 11, 2020, LabCorp announced details of a no charge antibody testing program in response to federal…
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…